| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |